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Abstract We describe here the cloning and sequencing of
human and mouse cDNAs encoding a putative GTP binding
protein. Sequence comparison shows that these cDNAs (named
eRFS) are likely to represent the orthologues of the yeast
Saccharomyces cerevisiae HBS1 gene and that the C-terminal
domains of the encoded proteins share structural features with
eukaryotic elongation factor eEF-1A and release factor 3 (eRF3)
families. The phylogenetic analysis suggests that eRFS proteins
and Hbs1p form a cluster of orthologous sequences branching
with the eRF3 family. Nevertheless, in yeast, the human eRFS
protein and Hbs1p do not complement eRF3/Sup35p thermo-
sensitive mutation and do not interact with eRF1.
z 1998 Federation of European Biochemical Societies.
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1. Introduction
G proteins are a superfamily of GTP hydrolases involved in
a wide variety of cellular mechanisms. Among them, trans-
lation elongation factors eEF-1A (also named EF-1K) and
eEF-2, and release factor 3 (eRF3 in eukaryotes) interact
transiently with the ribosome and catalyse GTP hydrolysis
to aid in the progress of the translation process. eRF3, which
shares high similarities with eEF-1A in its C-terminal domain,
can be regarded as a paralogous group in eEF-1A phylogeny.
In vitro, eRF3 binds to the release factor 1 (eRF1) and its
GTPase activity stimulates eRF1 activity [1,2]. The C-terminal
domain of eRF3 is required for yeast viability but the unique
sequence at the N-terminus is non-essential [3]. Recently, two
mouse genes, GSPT1 and GSPT2, encoding proteins highly
similar to human eRF3 have been sequenced [4]. Both mouse
proteins directly interact with human eRF1 con¢rming the
results obtained with eRF3 from yeast, human and Xenopus
laevis [2,5,6].
Hbs1p, the translation product of the Saccharomyces cere-
visiae HBS1 gene, was classi¢ed as an eEF-1A-like protein
because of its similarities with eEF-1A. Moreover, an in-
creased copy number of HBS1 suppressed the growth defect
of a double mutant in SSB1 and SSB2 genes [7]. Ssb1/2p are
molecular chaperones of the HSP70 family that are associated
with translating ribosomes and may aid in the passage of the
nascent polypeptide through the ribosome channel into the
cytosol. Thus, it was suggested that Hbs1p has an eEF-1A-
like activity, which is more e⁄cient than the normal eEF-1A
and could compensate for the less accessible aminoacyl-tRNA
binding site in ssb1ssb2 mutant strains [7].
In a recent search for chromosomal ampli¢cations harbour-
ing potential oncogenes in pancreatic cancer, CGH studies
revealed an ampli¢cation on 6q23^24 [8]. Whereas the c-myb
oncogene was identi¢ed as the most likely candidate oncogene
in this ampli¢cation, a gene encoding a protein highly similar
to the eRF3 family was found among the coampli¢ed genes
[9].
In this paper, we describe the cloning and sequencing of the
human and mouse cDNAs encoding this eRF3-like protein
that was named eRFS for ‘RF similar’. Our phylogenetic
studies show that eRFS gene is likely to correspond to the
mammalian homologue of S. cerevisiae HBS1 and reveal the
relationship between the eEF-1A, eRF3 and eRFS families.
We also show that HBS1 and eRFS genes cannot complement
yeast eRF3/sup35(ts) mutants and that Hbs1p does not inter-
act with eRF1 or eRF3.
2. Materials and methods
2.1. Yeast strains and media
The S. cerevisiae strains 2-33G-D373 and 57-132-L28-2V-P3982
used for complementation experiments were previously described [2].
The S. cerevisiae strains SFY 526 [10] and HF7c [11] were used in
two-hybrid assays. Yeast cultures were grown in YPD (1% yeast ex-
tract/2% peptone/2% glucose) or in SC synthetic minimal medium
(0.67% yeast nitrogen base/2% glucose with appropriate auxotrophic
supplements). Yeast transformations were performed according to
Gietz et al. [12]. The plate colour assay with X-gal as substrate was
essentially as described [13].
2.2. Plasmids
Unless indicated otherwise, DNA and RNA manipulations were
carried out according to Sambrook et al. [14]. The multicopy
(pSTR7) or centromeric (pUCH-U2) plasmids containing the com-
plete yeast SUP35 gene were described previously [15,16]. Plasmid
pGADGH/SUP35 was constructed as follows: a 2-kb fragment of
the S. cerevisiae SUP35 sequence was ampli¢ed by polymerase chain
reaction (PCR) using primers 26 (5P-CGCGGATCCGGATTCA-
AACCAAGGC-3P) and 16 (5P-CAAGACTCGAGCTCGGCAATTT-
TAAC-3P), digested with BamHI and XhoI and inserted in BamHI-
XhoI sites of pGADGH. Plasmid pGBT9/SUP35 was constructing by
subcloning a 2-kb EcoRI-XhoI fragment of the S. cerevisiae SUP35
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sequence generated by PCR using primers 57 (5P-GCAGAAT-
TCTCGGATTCAAAC-3P) and 16 (5P-CAAGACTCGAGCTCGG-
CAATTTTAAC-3P) in the EcoRI-SalI sites of plasmid pGBT9. Plas-
mid pGADGH/SUP45 was constructed by subcloning a 1.3-kb
BamHI-XhoI fragment of the S. cerevisiae SUP45 sequence generated
by PCR using primers 56 (5P-CGCGGATCCGGATAACGAG-3P)
and 64 (5P-GATCCCTCGAGTTCGTCATAATATTC-3P) in the
BamHI-XhoI sites of plasmid pGADGH. Plasmid pGBT9/HBS1
was constructing by subcloning a 1.8-kb BamHI-SalI fragment of
the S. cerevisiae HBS1 sequence generated by PCR using primers
76-BamHI (5P-TCGAGAGGATCCACAGTGACTAC-3P) and 77-
SalI (5P-CATCTATTTTCGTCGACCTACTGAG-3P) in the BamHI-
SalI sites of pGBT9. Plasmid pFL38/HBS1 was constructed by insert-
ing a 3-kb fragment containing the HBS1 promoter and coding se-
quence in pFL38 centromeric vector [17]. Plasmid pFL44/hu-eRFS
was constructed as follows: plasmid pFL44S [17] was digested by
EcoRI and BamHI and ligated with the 0.7-kb EcoRI-BamHI frag-
ment of pRS426/XSUP35 [2] containing the yeast SUP35 promoter.
The resulting plasmid was cut with BamHI and XbaI and ligated with
the 2.4-kb BamHI-XbaI fragment from pSPORT/hu-eRFS which con-
tained the full-length cDNA of the human eRFS gene. Plasmid
pYX242/hu-eRFS was constructed by subcloning the 2.4-kb BamHI-
XbaI fragment of pSPORT/hu-eRFS in the BamHI-NheI sites of
pYX242 (RpD Systems).
2.3. Selection and sequencing of human and mouse eRFS cDNAs
The human eRFS gene was isolated by chance in a search for genes
harbouring the chromosomal area 6q24 [9]. Exon trapping was per-
formed with genomic DNA from the 620-kb Yeast Arti¢cial Chro-
mosome ICRFy900A0311Q according to the detailed protocol of
Church et al. [18]. One of the exon trap fragments encoding a se-
quence similar to eEF-1A was used as a probe for the screening of
an oligo(dT)-primed pancreas cDNA library at stringent conditions.
Only one positive cDNA clone with an insert size of 1927 bp was
found and sequenced on both strands. As the isolated cDNA clone
did not contain the full-length sequence, the 5P end was cloned with
the 5P RACE system (Gibco BRL). The resulting 2508-bp cDNA
sequence (GenBank accession number U87791) was named human
eRFS.
The mouse eRFS cDNA was selected fortuitously during the screen-
ing of a 10-day mouse embryo cDNA library (Novagen) with the 2-kb
ApaI fragment of human GSPT1 cDNA encoding eRF3 [19]. Four
positive clones were revealed in non-stringent conditions and the in-
serts were sequenced on both strands using standard methods [20].
Two of the cDNAs with almost perfect identity with human GSPT1
cDNA likely correspond to the mouse homologue of the GSPT1 gene.
Both of the remaining cDNAs were identical and shared lower ho-
mologies with GSPT1 cDNA. The 5P end of the cDNA was obtained
by the 5P RACE method using the RACE kit from Boehringer and
three independent preparations of total mouse RNA. The resulting
2663-bp cDNA (GenBank accession number AF087672) was named
mouse eRFS.
2.4. Northern blot
Northern blot membranes containing 2 Wg of poly(A) mRNAs
from di¡erent human tissues or from mouse embryos at various stages
(Clontech) were probed as described [14] with radiolabelled DNA
fragments of the same origin. The membranes were washed at strin-
gent conditions and eRFS mRNA bands were revealed by autoradiog-
raphy.
2.5. Computer-assisted sequence comparisons and phylogenetic analyses
Alignment of the sequences was carried out visually with the help of
the ED program of the MUST package version 1.0 [21]. Phylogenetic
trees were constructed with maximum likelihood (ML), maximum
parsimony (MP) and distance-based methods (neighbour joining,
NJ) with the programs PROTML [22] version 2.3, PAUP version
3.1 and NJ in the MUST package version 1.0 [21], respectively. The
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Fig. 1. Alignment of the predicted amino acid sequences of human and mouse eRFS. Conserved GTP binding motifs G1^G4 [25] are indicated
by solid lines, identical amino acids by asterisks and similar amino acids by dots.
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distances were computed with the substitution model of Kimura [23].
MP trees were obtained by 100 random addition heuristic search
replicates and ML trees by the quick add OTUs search, with the
JTT model of amino acid substitution and retaining the 5000 top
ranking trees (options -jf -q -n 5000). Bootstrap proportions were
calculated by the analysis of 1000 replicates for MP and NJ analyses.
For ML analysis, bootstrap proportions were computed using the
RELL method [24] because of computing time limitations.
3. Results
3.1. Sequence analysis of human and mouse cDNAs
homologous to yeast HBS1 gene and structure of
the predicted proteins
The human eRFS cDNA was isolated in a screen originally
intended to ¢nd new genes from the chromosomal region 6q24
which shows chromosomal aberrations, e.g. high copy amplif-
ications and heterozygous deletions, in pancreatic cancer [9].
The mouse eRFS cDNA was isolated from a 10-day mouse
embryo cDNA library during the search for mouse eRF3
cDNA.
The nucleotide sequence of human eRFS cDNA revealed a
long open reading frame (ORF) encoding a polypeptide of
684 amino acids (Fig. 1) with a predicted molecular mass of
approximately 75 kDa. The protein contains two domains: a
253 ami-o acid N-terminal part, showing no homology to any
known protein and a 431-amino acid C-terminal domain with
characteristic consensus GTP binding sites [25].
The mouse eRFS cDNA contains a single ORF encoding a
polypeptide of 600 amino acids having 89% identity with the
human polypeptide (Fig. 1). The major di¡erences were found
in the N-terminal part of mouse polypeptide, which was 87
amino acids shorter than human eRFS and shared only 70%
identity with the remaining human eRFS N-terminal portion.
This divergence was con¢rmed by three independent RACE
experiments. The C-terminus harbouring the GTPase consen-
sus motifs was 97% identical to the human polypeptide C-
terminal domain.
3.2. Sequence comparison and phylogenetic analysis of eRFS
and Hbs1p
The protein sequences homologous to eRFS were identi¢ed
by a BLAST search using the eRFS sequence from mouse as
the query sequence. This search revealed a high similarity of
mouse eRFS with Hbs1p from S. cerevisiae and with a se-
quence from Caenorhabditis elegans. Because Hbs1p was clas-
si¢ed ¢rst as an eEF-1A-like protein but also because it was
noted that Hbs1p shares high similarity with eRF3 [7], se-
quences of the eRFS family were compared with those of
the eEF-1A and eRF3 families. With the exception of the
non-conserved N-terminal domain in eRFS and eRF3 fami-
lies, the C-terminal domain of the predicted eRFS proteins
can be unambiguously aligned with the archaebacterial EF-
1A and the eukaryotic eEF-1A and eRF3 over 401 amino acid
positions. The highest similarities were found in the region of
the conserved GTP binding motifs G1^G4 shown for eRFS in
Fig. 1.
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Fig. 2. Phylogenetic tree based on comparison of major eEF-1A, eRF3, and eRFS sequences from Eukaryotes. The outgroup consists of di-
verse EF-1A sequences from Archaea. The tree was constructed with the maximum likelihood method. Bootstrap proportions are shown below
the corresponding nodes. For each sequence data base access numbers are indicated in parentheses. The scale bar indicates the numbers of sub-
stitutions per site for a unit branch length.
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The phylogenetic trees inferred with MP, NJ and ML meth-
ods were very similar and only the ML tree is shown (Fig. 2).
The archaebacterial EF-1A was used as an outgroup and the
root was thus located at the base of the Archaea. The close
relationship of eukaryotic eEF-1A, eRF3 and eRFS was re-
inforced by the sharing of a small insertion, located at posi-
tion 121^127 of human eEF-1A, which is only present in
crenotes [26]. The major feature of the tree is the existence
of four monophyletic groups, strongly supported by statistical
analysis (bootstrap values close to 100%): the archaebacterial
EF-1A, the eukaryotic eEF-1A, the eukaryotic eRF3 and the
eukaryotic eRFS.
Our analysis shows that eukaryotic eRF3 and eRFS are
sister groups, suggesting that an initial duplication created
the eEF-1A encoding gene and an ancestral RF gene, which
underwent another duplication, leading to the eRF3 and eRFS
genes. In fact, the evolutionary rates of the di¡erent paralo-
gous genes are quite di¡erent, as evidenced by the di¡erence
in branch lengths (Fig. 2). A comparison of the distances
between the three species simultaneously available for the
three proteins (Saccharomyces, Caenorhabditis and Homo) re-
vealed that eRF3 and eRFS evolved about 2.9 and 4.9 times
faster than eEF-1A, respectively.
3.3. HBS1 and human eRFS gene cannot complement yeast
sup35 thermosensitive mutants
We next addressed the question of whether the eRFS pro-
tein family is involved in translation termination. For this
purpose, we tested the ability of human eRFS and Hbs1p to
restore growth at 37‡C and to complement the suppressor
phenotype of eRF3/sup35(ts) mutants.
Yeast strain 2-33G-D373 containing the eRF3/sup35(ts)
mutation was transformed with multicopy or centromeric
plasmids carrying either the yeast HBS1 gene or the human
eRFS gene for complementation assays. The yeast eRF3/
SUP35 gene expressed from the same vectors served as con-
trol. For each plasmid, ¢ve independent transformants were
picked at the permissive temperature (25‡C) and analysed at
the restrictive temperature (37‡C). As shown in Fig. 3, none of
the plasmids carrying either the S. cerevisiae HBS1 gene (Fig.
3A) or the human eRFS gene (Fig. 3B) was able to compen-
sate the growth defect of eRF3/sup35(ts) mutants at 37‡C.
These results suggest that the proteins encoded by the eRFS
family cannot act as eRF3 in the translation termination com-
plex.
To go further, we studied the growth potential of trans-
formants overexpressing Hbs1p in the 57-132-L28-2V-P3982
yeast strain carrying various nonsense alleles which confer
di¡erent types of auxotrophy. Whichever the nonsense muta-
tion tested, ade1-14, his7-1 or lys2-89, Hbs1p did not in£uence
the e⁄ciency of suppression caused by the sup35-57 mutation
(data not shown). This result indicates that Hbs1p overexpres-
sion does not produce an antisuppressor phenotype and can-
not compete with the suppressor e¡ect of Sup35p mutations,
and thus strongly suggests that Hbs1p does not contain eRF3-
like release factor activity.
3.4. Hbs1p does not interact with the components of the
translation termination complex
The GAL4-based two-hybrid system [27,28] was employed
to test the interaction of Hbs1p with S. cerevisiae eRF3/
Sup35p and eRF1/Sup45p. The plasmid carrying the Hbs1p-
Gal4 fusion protein was transformed in di¡erent pair-wise
combinations with eRF3/Sup35p-Gal4 or eRF1/Sup45p-Gal4
fusion proteins into yeast recipient strains carrying either
LacZ or HIS3 reporter genes (Table 1). The activation of
the GAL1 promoter was assayed by colony colour using the
chromogenic substrate X-gal (LacZ reporter) and by growth
on selective medium lacking histidine (HIS3 reporter). The
interaction between yeast eRF3/Sup35p and eRF1/Sup45p re-
ported previously [5] served as a control. The results showed
that neither eRF1/Sup45p nor Hbs1p fusion proteins ex-
pressed alone, nor double transformants expressing Hbs1p
fusion protein together with eRF1/Sup45p or eRF3/Sup35p
fusion protein activated reporter genes (Table 1). These results
indicate that Hbs1p does not interact with eRF3 or eRF1.
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Fig. 4. Northern blot analysis of poly(A)-tailed mRNA from di¡er-
ent human tissues probed with human eRFS cDNA (A) and from
mouse embryo at di¡erent days post coitum (dpc) probed with
mouse eRFS cDNA (B).
Fig. 3. Complementation of the yeast eRF3/sup35(ts) mutation by
the S. cerevisiae HBS1 gene (A) or the human eRFS gene (B). The
S. cerevisiae temperature-sensitive strain 2-33G-D373 was trans-
formed by the plasmids indicated. Five Leu or Ura transformants
were replica-plated on YPD plates and incubated at 25‡C or 37‡C.
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3.5. Expression of human and mouse eRFS mRNAs in various
tissues
The pattern of eRFS poly(A)-tailed mRNA was examined
in various human tissues by Northern blot hybridisation using
human eRFS cDNA as a probe. A 3.0-kb transcript was de-
tected in all tissues examined, though transcript levels were of
low abundance in lung and kidney and highly abundant in
heart and skeletal muscles (Fig. 4A). Analysis of mouse em-
bryo mRNAs with a mouse eRFS cDNA probe showed that
the eRFS gene is strongly expressed at least during the late
stages of mouse embryo development (Fig. 4B).
4. Discussion
In this study, we present the sequence of human and mouse
cDNAs, of which the putative encoded polypeptides bear the
conserved motifs of the GTP binding protein family. Phylo-
genetic analysis reveals that these polypeptides, named eRFS,
are likely to correspond to the mammalian homologues of the
translation product of the S. cerevisiae HBS1 gene. The func-
tion of Hbs1p is not yet established. It has been reported that
Hbs1p may be involved in translation elongation and specu-
lated that Hbs1p could act as eEF-1A and bring the amino-
acyl-tRNA to the ribosome [7]. The resemblance of Hbs1p to
eRF3 was also mentioned [29].
Our phylogenetic study shows that the mammalian eRFS
together with a protein of C. elegans are the orthologues of
Hbs1p, which form a monophyletic group. This analysis in-
dicates that three paralogous genes exist in eukaryotes, encod-
ing eEF-1A, eRF3 and eRFS, and suggests a sister group
relationship between eRF3 and eRFS. The presence of a var-
iable domain at the N-terminus also distinguishes eRF3 and
eRFS from eEF-1A. However, the precise relationship be-
tween eRF3 and eRFS is di⁄cult to infer because the
branches of eRF3 and eRFS are much longer than that of
eEF-1A and might be grouped together only because of a tree
reconstruction artefact known as the long branch attraction
phenomenon [30]. The clear di¡erences in evolutionary rate
demonstrate that the functional constraints are quite di¡erent
for the three proteins. As expected, eEF-1A is the most con-
strained, because of its central role in translation and its in-
teraction with many other proteins. The evolutionary rate of
eRFS is the highest suggesting limited functional constraints.
The function of eRFS was then evaluated on the basis of
the phylogenetic study. Genetic analysis using eRF3/sup35(ts)
mutants and the two-hybrid system clearly shows that neither
human eRFS nor Hbs1p can replace eRF3 in the translation
termination complex or interact with the components of this
complex, i.e. eRF1 or eRF3. Moreover, in an in vitro assay
[31], mouse eRFS did not exhibit GTPase activity in the pres-
ence of ribosomes and human eRF1 (L. Frolova, personal
communication). Together, these results strongly suggest
that the eRFS protein family is not directly involved in the
translation termination process.
One can speculate about the function of eRFS in transla-
tion. A role of Hbs1p in translation elongation remains pos-
sible. However, a role in another cellular mechanism must be
considered. Recently, it was demonstrated that an evolutio-
narily conserved GTP binding protein, named U5-116kD,
closely related to the ribosomal elongation factor eEF-2, is
a component of U5 snRNP which is essential for pre-
mRNA splicing [32]. Like eRF3 and eRFS, U5-116kD protein
contains an N-terminal domain which is absent in eEF-2.
Nevertheless, the presence of a variable N-terminal domain
cannot account for the functional di¡erences of paralogous
GTP binding proteins. Indeed, it was demonstrated in vitro
that the C-terminal part of X. laevis eRF3 carries the GTPase
activity required for eRF1 stimulating activity [1,2,6]. In yeast,
the expression of the eRF3/Sup35p C-terminal part alone gen-
erates an antisuppressor phenotype [3]. Thus, despite extensive
structural homologies in the conserved C-terminal domain,
the paralogous proteins, eEF-1A, eRF3 and eRFS, may
have non-overlapping functions and their close phylogenetic
relationship does not allow a conclusion regarding their con-
tribution to the same cellular process. Clearly, further exper-
imentation such as the disruption of the HBS1 gene in yeast is
required to elucidate the function of the eRFS family.
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